---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-280223"
form_type: "8-K"
ticker: "CALC"
cik: "0001534133"
company_name: "CalciMedica, Inc."
filed_at: "2026-06-24T10:50:38+00:00"
generated_at: "2026-06-24T10:55:16.703183+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# CalciMedica amends loan with Avenue: extends maturity to 2029, ups convertible amount to $3M

## Summary
- Loan principal $10M unchanged; interest-only extended to Sep 2027, maturity to Sep 2029.
- Lender's conversion option increased from $1M to $3M at $1.00/share; new 1M-share warrant issued at same price.
- Company granted monthly Put Option to force conversion up to 20% of 15-day avg volume if VWAP >1.5x conversion price.
- Existing warrant exercise price reduced from $2.32 to $1.00; beneficial ownership cap set at 4.99% (expandable to 19.99%).

## SEC filing metadata
- accession: 0001193125-26-280223
- form_type: 8-K
- ticker: CALC
- cik: 0001534133
- company_name: CalciMedica, Inc.
- filed_at: 2026-06-24T10:50:38+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534133/000119312526280223/0001193125-26-280223-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534133/000119312526280223/d40651d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-280223
- JSON: https://secwatch.observer/filing/0001193125-26-280223.json
- Plain text: https://secwatch.observer/filing/0001193125-26-280223.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.